These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 4559271)
21. Moenomycin. VII. Isolation and properties of further components of the antibiotic moenomycin. Schacht U; Huber G J Antibiot (Tokyo); 1969 Dec; 22(12):597-602. PubMed ID: 4312665 [No Abstract] [Full Text] [Related]
23. Studies on antibiotic SF-837, a new antibiotic. 3. Isolation and properties of minor components. Tsuruoka T; Ezaki N; Shomura T; Amano S; Inouye S J Antibiot (Tokyo); 1971 Jul; 24(7):476-82. PubMed ID: 5562044 [No Abstract] [Full Text] [Related]
24. Antibiotic AB-65, a new antibiotic from Saccharomonospora viride. Tamura A; Takeda I J Antibiot (Tokyo); 1975 May; 28(5):395-7. PubMed ID: 1165224 [No Abstract] [Full Text] [Related]
25. Dactylarin, a new antiprotozoal antibiotic from Dactylaria lutea. Kettner M; Nemec P; Kovác S; Balanová J J Antibiot (Tokyo); 1973 Nov; 26(11):692-6. PubMed ID: 4792118 [No Abstract] [Full Text] [Related]
26. Studies on antibiotic SF-837, a new antibiotic. I. The producing microorganism and isolation and characterization of the antibiotic. Tsuruoka T; Shomura T; Ezaki N; Watanabe H; Akita E J Antibiot (Tokyo); 1971 Jul; 24(7):452-9. PubMed ID: 5562042 [No Abstract] [Full Text] [Related]
27. In vitro antiprotozoal activity of (S)-cis-Verbenol against Leishmania spp. and Trypanosoma cruzi. Yaluff G; Vega C; Alvarenga N Acta Trop; 2017 Apr; 168():41-44. PubMed ID: 28062234 [TBL] [Abstract][Full Text] [Related]
35. The Widespread Anti-Protozoal Action of HIV Aspartic Peptidase Inhibitors: Focus on Plasmodium spp., Leishmania spp. and Trypanosoma cruzi. Santos AL; d'Avila-Levy CM; Kneipp LF; Sodré CL; Sangenito LS; Branquinha MH Curr Top Med Chem; 2017; 17(11):1303-1317. PubMed ID: 27784256 [TBL] [Abstract][Full Text] [Related]
36. In vitro antiprotozoal activity of some xanthones isolated from the roots of Andrographis paniculata. Dua VK; Verma G; Dash AP Phytother Res; 2009 Jan; 23(1):126-8. PubMed ID: 18683849 [TBL] [Abstract][Full Text] [Related]
37. Carbonic anhydrases from Trypanosoma and Leishmania as anti-protozoan drug targets. Vermelho AB; Capaci GR; Rodrigues IA; Cardoso VS; Mazotto AM; Supuran CT Bioorg Med Chem; 2017 Mar; 25(5):1543-1555. PubMed ID: 28161253 [TBL] [Abstract][Full Text] [Related]
38. In vitro antiprotozoal and cytotoxic activity of 33 ethonopharmacologically selected medicinal plants from Democratic Republic of Congo. Musuyu Muganza D; Fruth BI; Nzunzu Lami J; Mesia GK; Kambu OK; Tona GL; Cimanga Kanyanga R; Cos P; Maes L; Apers S; Pieters L J Ethnopharmacol; 2012 May; 141(1):301-8. PubMed ID: 22394563 [TBL] [Abstract][Full Text] [Related]
39. In vitro inhibitory effects of palmatine from Enantia chlorantha on Trypanosoma cruzi and Leishmania infantum. Nkwengoua ET; Ngantchou I; Nyasse B; Denier C; Blonski C; Schneider B Nat Prod Res; 2009; 23(12):1144-50. PubMed ID: 19662580 [TBL] [Abstract][Full Text] [Related]
40. Tolypomycin, a new antibiotic. 3. Isolation and characterization of tolypomycin Y. Kishi T; Yamana H; Muroi M; Harada S; Asai M J Antibiot (Tokyo); 1972 Jan; 25(1):11-5. PubMed ID: 4622052 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]